International epidemiology of prostate cancer: Geographical distribution and secular trends
Top Cited Papers
- 6 February 2009
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 53 (2), 171-184
- https://doi.org/10.1002/mnfr.200700511
Abstract
This review outlines current international patterns in prostate cancer incidence and mortality rates and survival, including recent trends and a discussion of the possible impact of prostate‐specific antigen (PSA) testing on the observed data. Internationally, prostate cancer is the second most common cancer diagnosed among men (behind lung cancer), and is the sixth most common cause of cancer death among men. Prostate cancer is particularly prevalent in developed countries such as the United States and the Scandinavian countries, with about a six‐fold difference between high‐incidence and low‐incidence countries. Interpretation of trends in incidence and survival are complicated by the increasing impact of PSA testing, particularly in more developed countries. As Western influences become more pronounced in less developed countries, prostate cancer incidence rates in those countries are tending to increase, even though the prevalence of PSA testing is relatively low. Larger proportions of younger men are being diagnosed with prostate cancer and living longer following diagnosis of prostate cancer, which has many implications for health systems. Decreasing mortality rates are becoming widespread among more developed countries, although it is not clear whether this is due to earlier diagnosis (PSA testing), improved treatment, or some combination of these or other factors.Keywords
This publication has 86 references indexed in Scilit:
- Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975–2004BJU International, 2008
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007
- Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testingBritish Journal of Cancer, 2006
- Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East AngliaBritish Journal of Cancer, 2006
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survivalBritish Journal of Cancer, 2006
- Changing demography of prostate cancer in AsiaEuropean Journal of Cancer, 2005
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- Survey of the rate of PSA testing in general practiceBritish Journal of Cancer, 2001